FOXO4-DRI Protocol
Dosing & Research
Last Updated: September 4, 2026
Chemical Identity
- Molecular Formula
- C228H388N86O64
- Molecular Weight
- 5358.06 g/mol
- CAS Number
- 2460055-10-9
Senolytic research, Cellular senescence clearance, Aging-biomarker studies, Tissue rejuvenation models
Half-Life
Not Well Characterized In Humans
Administration
Subcutaneous
Frequency
Every Other Day X 3 Doses Per Cycle (days 1, 3, 5)
How It Works
- Senolytic research
- Cellular senescence clearance
- Aging-biomarker studies
- Tissue rejuvenation models
Dosing Structure
Dose
~25 mg per injection
Frequency
Every Other Day X 3 Doses Per Cycle (days 1, 3, 5)
Notes
Inject: Abdominal Fat (subcutaneous). Anecdotal Protocols Suggest Monthly Cycles.
Example Protocols
Dose: ~25 mg per injection
Frequency: Every Other Day X 3 Doses Per Cycle (days 1, 3, 5)
Duration: 5 Days Per Cycle
Off Period: Not listed
Find Research Grade FOXO4-DRI
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Inject: Abdominal fat (subcutaneous).
•
Anecdotal protocols suggest monthly cycles.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.